Pfizer faces investor concerns over declining coronavirus product sales and loss of exclusivity on key drugs, prompting a potential turnaround. While 2025 may not see as many stock splits as 2024, interest in AI stocks and recovery stories could drive market momentum, especially with anticipated interest rate cuts benefiting consumer goods and growth companies. Investors are likely to focus on valuations, as many stocks appear expensive following a strong market performance.
read moreAdria Cimino
0 posts last weekOracle Emerges as a Strong AI Investment Alternative to Nvidia
Nvidia, a leader in AI chips, has seen a recent decline in stock price, prompting a shift in focus to Oracle, which is gaining momentum in the AI market. Oracle’s cloud infrastructure revenue surged 45% year-over-year, and strategic partnerships with major cloud providers enhance its growth potential. With a forward earnings valuation of 26 times, Oracle presents a compelling investment opportunity in the evolving AI landscape.
read moreAmazon predicted to outperform Nvidia in AI stock performance by year end
Amazon is predicted to outperform Nvidia by year-end, benefiting from its diverse revenue streams beyond AI, including a booming e-commerce business and strong growth in Amazon Web Services (AWS). With over 200 million Prime members and a significant annual revenue run rate of $105 billion for AWS, Amazon’s resilience in uncertain economic conditions positions it as a safer investment compared to Nvidia, which has recently lost momentum.
read more